Status:
UNKNOWN
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
Lead Sponsor:
Assiut University
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
Describe strengths and limitations of FDG PET/CT for staging. Evaluate the utility of PET/CT in assessment of therapy response and restaging
Detailed Description
Lung cancer is one of the most common cancers and it represents the main cause of cancer mortality worldwide. It is histopathological classified into main groups: Small cell lung cancer (15%) and Non...
Eligibility Criteria
Inclusion
- Patients with pathologically proven lung cancer and referred to nuclear medicine unit to perform PET/CT for staging and patient referred for assessment of response of therapy and re staging.
Exclusion
- Pregnant women.
- Patients unable to sleep in a fixed position for 20 minutes.
- Severely ill patients who aren't capable of complying with study procedures or comatose patients.
- Patients with known second primary
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04395651
Start Date
May 1 2020
End Date
June 1 2021
Last Update
May 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.